BSGM — Biosig Technologies Balance Sheet
0.000.00%
Last trade - 00:00
- $15.79m
- $15.63m
- $0.02m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 12.1 | 28.3 | 11.7 | 0.458 | 0.293 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | — | 0.009 | 0.024 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 12.8 | 29.3 | 13.9 | 1.13 | 0.528 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.895 | 0.595 | 1.26 | 1.37 | 0.921 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 14.2 | 30.4 | 15.5 | 4.11 | 1.8 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.03 | 5.11 | 2.58 | 3.26 | 4.58 |
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.86 | 5.91 | 3.17 | 3.69 | 4.71 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 11.4 | 24.5 | 12.3 | 0.418 | -2.91 |
Total Liabilities & Shareholders' Equity | 14.2 | 30.4 | 15.5 | 4.11 | 1.8 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |